Specific Nutritional Biomarker Profiles in Mild Cognitive Impairment and Subjective Cognitive Decline Are Associated With Clinical Progression: The NUDAD Project

F.A. de Leeuw, W.M. van der Flier, B.M. Tijms, P. Scheltens, V.M. Mendes, B. Manadas, J. Bierau, N. van Wijk, E.G.H.M. van den Heuvel, M.H. Mohajeri, C.E. Teunissen, M.I. Kester

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1513.e1-1513.e17
Number of pages17
JournalJournal of the American Medical Directors Association
Volume21
Issue number10
DOIs
Publication statusPublished - 1 Oct 2020

Keywords

  • alzheimers-disease
  • cerebrospinal-fluid
  • clinical progression
  • cognitive decline
  • dementia
  • diagnostic guidelines
  • mild cognitive impairment
  • national institute
  • nutrients
  • nutritional biomarker
  • nutritional biomarker profiles
  • plasma
  • risk
  • s-adenosylmethionine
  • serum
  • subjective cognitive decline
  • total cholesterol levels
  • DEMENTIA
  • ALZHEIMERS-DISEASE
  • TOTAL CHOLESTEROL LEVELS
  • CEREBROSPINAL-FLUID
  • NATIONAL INSTITUTE
  • PLASMA
  • Nutrients
  • RISK
  • SERUM
  • S-ADENOSYLMETHIONINE
  • DIAGNOSTIC GUIDELINES

Cite this